Clinical trial
Novel Screening MRI for the Detection of Prostate Cancer
NCT02131207 is registered in ClinicalTrials.gov with Case Comprehensive Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Novel Screening MRI for the Detection of Prostate Cancer
- Lead sponsor
- Case Comprehensive Cancer Center
- Phase
- Observational
- Overall status
- Terminated
- Start date
- September 10, 2014
- Completion date
- December 8, 2017
- Enrollment
- 139 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer